Create Alert
Watchlist

Wockhardt

₹1,462.80
-14.10 (0.95%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
1,476.90
Prev. Close
1,476.90
Volume
70,725
Total traded value
10.35 Cr
Upper Circuit
1,772.20
Lower Circuit
1,181.60

Fundamentals

Market Cap₹23,986Cr
ROE-1.08%
P/E Ratio(TTM)-195.00
EPS(TTM)-7.57
P/B Ratio5.51
Dividend Yield0.00%
Industry P/E35.33
Book Value267.90
Debt to Equity0.46
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About WOCKHARDT Limited

Wockhardt is a global pharmaceutical and biotech company focused on antibiotic research, developing innovative medicines to fight drug-resistant infections. The company's mission is to save lives across the world by creating new antibiotics to tackle the growing global health crisis of antimicrobial resistance. It is the only company in the world where the USFDA has granted special status for six of its anti-bacterial discovery programmes.;
Parent OrganisationWOCKHARDT Limited
Managing DirectorDr. Murtaza Habil Khorakiwala
NSE SymbolWOCKPHARMA

Shareholding Pattern

Sep '24
Nov '24
Dec '24
Mar '25
Jun '25
Promoters
49.09%
Retail And Others
32.62%
Mutual Funds
8.02%
Foreign Institutions
7.29%
Other Domestic Institutions
2.98%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
102.84
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.38
Emcure Pharmaceuticals
NA
(0.00%)
33.75
Concord Biotech
NA
(0.00%)
47.65